title: Association of β-Blocker Treatment With Adverse Outcomes in Hypertensive Patients Undergoing Noncardiac Surgery--Reply.
authors.affiliation: The Cardiovascular Research Center, Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark2Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California3Department of Medicine, Stanford University School.
authors.forename: Mads E
authors.initials: ME
authors.lastname: Jørgensen
authors.affiliation: Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California3Department of Medicine, Stanford University School of Medicine, Stanford, California.
authors.forename: Mark A
authors.initials: MA
authors.lastname: Hlatky
authors.affiliation: The Cardiovascular Research Center, Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
authors.forename: Charlotte
authors.initials: C
authors.lastname: Andersson
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D005260:Female; D013502:General Surgery; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D009203:Myocardial Infarction / Q000139:chemically induced*; D012042:Registries; D020521:Stroke / Q000139:chemically induced*
chemical_list: D000319:Adrenergic beta-Antagonists